Article Text
Abstract
Systemic lupus erythematosus (SLE) is not an uncommon condition. Most neurologists are well aware that it can cause a wide range of neurological complications, and SLE almost invariably appears on ‘differential diagnosis’ lists in cases of clinical uncertainty. However, the precise nature of the manifestations of SLE in the central and peripheral nervous systems is perhaps less widely understood, and misperceptions about phenomenology and treatment are common. Here we survey some of the main primary neurological complications of SLE—‘neurolupus’—while acknowledging that secondary problems, either iatrogenic or relating to other consequences of SLE (eg, hypertensive CNS disease, for example, secondary to renal lupus) are neither less serious nor less treatable.
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
- Abstracts
- Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET
- Treat - to - target in systemic lupus erythematosus: recommendations from an international task force
- SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus
- Cardiac pathology of systemic lupus erythematosus
- Demyelination in rheumatic diseases
- Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus
- No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19
- HLA - DRB1*04 / * 13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus